USPSTF Reaffirms Folic Acid Recommendations During Pregnancy
In an important reaffirmation of prior guidance, the U.S. Preventive Services Task Force (USPSTF) “recommends that all persons planning to or who could become pregnant
In an important reaffirmation of prior guidance, the U.S. Preventive Services Task Force (USPSTF) “recommends that all persons planning to or who could become pregnant
Among 352 women in early pregnancy with moderate-to-severe nausea and vomiting, acupuncture and doxylamine–pyridoxine individually were efficacious but with modest effects of uncertain clinical importance.
In a study of 802 women in early pregnancy and a diagnosis of gestational diabetes, immediate treatment before 20 weeks’ gestation was more effective than
The unprecedented ruling by a federal court in Texas that the FDA’s approval of the abortifacient drug mifepristone is analyzed in a Viewpoint article. The
In the POSITIVE trial of select women with previous hormone receptor–positive early breast cancer, temporary interruption of endocrine therapy to attempt pregnancy did not confer
Live birth rates were not improved when prednisone was used daily from the time endometrial preparation for frozen-thawed embryo transfer through early pregnancy, a placebo-controlled
In 11,000 patients undergoing cesarean delivery, prophylactic use of tranexamic acid did not significantly reduce the risk of a composite outcome of maternal death or
The risk of maternal sepsis or death was reduced significantly in women planning a vaginal birth when they received a single dose of azithromycin, researchers
Among women of child-bearing potential, a study shows less prenatal exposure to phentermine-topiramate — a product that requires a Risk Evaluation and Mitigation Strategy (REMS)
A population-based cohort study from Ontario suggests no adverse infant outcomes from maternal treatment with opioids within 30 days of hospital discharge. “Although we endorse